Robert L. BuchananCo-Founder & CEO at Ambulero
Robert is an Entrepreneur-In-Residence at the University of Miami, Florida. He is a co-founder and CEO of Ambulero: a University of Miami spin-out focused on developing gene and cell therapies for treating vascular disease. He is also a Partner with Ventac Partners where he co-founded and was an early investor in two public companies: Idogen AB and RhoVac AB. Robert was Associate General Counsel with Biogen where responsibilities including supporting Biogen’s growing hemophilia, gene and cell therapy portfolios. Robert received a Ph.D (Biochemistry) from UCLA, a J.D from Suffolk University and he was a Biology Fellow (Neurogenetics) at CALTECH.